Confronting the Neuroinfectious Disease Epidemic a Call to Action for Neurology and Public Health
*Corresponding Author: Marita Coszo, Department of Medicine and Surgery, University of Parma, Italy, Email: Coszo-mta@gmail.comReceived Date: Sep 03, 2024 / Published Date: Sep 30, 2024
Citation: Marita C (2024) Confronting the Neuroinfectious Disease Epidemic a Callto Action for Neurology and Public Health. Neurol Clin Therapeut J 8: 227.
Copyright: © 2024 Marita C. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Abstract
Neuroinfectious diseases, including conditions such as meningitis, encephalitis, and neuro-HIV, pose a significant and growing threat to global public health. These infections can result in long-term neurological impairments and high mortality rates, particularly in resource-limited settings. Despite their devastating impact, neuroinfectious diseases often remain underrecognized and understudied. This paper aims to highlight the increasing burden of neuroinfectious diseases, review their global impact on neurological health, and call for urgent action to strengthen diagnostic capabilities, treatment protocols, and public health strategies. A comprehensive literature review was conducted to assess the epidemiology, clinical presentation, and outcomes of major neuroinfectious diseases. Data were drawn from peer-reviewed articles, reports from global health organizations, and case studies. Gaps in current neurology training and healthcare infrastructure were also identified through expert consultations. The findings reveal that neuroinfectious diseases disproportionately affect low- and middle-income countries, where diagnostic tools and treatments are often lacking. Delayed diagnosis and inadequate management contribute to high rates of morbidity and mortality. Furthermore, there is a lack of integration between neurology and infectious disease specialties, exacerbating the challenges in managing these conditions.